Rousselot® Biomedical launches Quali-Pure™ -- MEDICA - World Forum for Medicine

19/10/2021

ROUSSELOT B.V.

Rousselot® Biomedical launches Quali-Pure™

Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions launches Quali-Pure™, a range of gelatins for biomedical applications with controlled endotoxin levels. The latest addition to Rousselot Biomedical’s rapidly expanding portfolio, Quali-Pure has been specifically designed for a variety of applications including embolization, wound healing, drug delivery, vaccines and hemostatics. Quali-Pure delivers biocompatibility, biodegradability, controlled endotoxin levels, and batch-to-batch consistency, and fully supports medical device compliance with ISO 22442 and the new EU Medical Device Regulation (MDR) standards.

Exhibitor Data Sheet